CRISPR-Based Synthetic Transcription Factors In Vivo: The Future of Therapeutic Cellular Programming
Matthew Pandelakis(Arizona State University), Mo R. Ebrahimkhani(University of Pittsburgh), Elizabeth Delgado(Arizona State University)
Cited by 65
Related Papers
An enhanced CRISPR repressor for targeted mammalian gene regulation
|Nature Methods|2018|536
Cas9 gRNA engineering for genome editing, activation and repression
|Nature Methods|2015|356
Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease
|Nature Medicine|2011|212
CRISPR transcriptional repression devices and layered circuits in mammalian cells
|Nature Methods|2014|198